Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-137.57%
operating margin TTM
-138.02%
revenue TTM
38.33 Million
revenue per share TTM
2.47$
valuation ratios | |
|---|---|
| pe ratio | -0.76 |
| peg ratio | 0.03 |
| price to book ratio | 16.07 |
| price to sales ratio | 1.05 |
| enterprise value multiple | -0.55 |
| price fair value | 16.07 |
profitability ratios | |
|---|---|
| gross profit margin | 39.06% |
| operating profit margin | -138.02% |
| pretax profit margin | -133.4% |
| net profit margin | -137.57% |
| return on assets | -73.14% |
| return on equity | -390.76% |
| return on capital employed | -228.7% |
liquidity ratio | |
|---|---|
| current ratio | 1.09 |
| quick ratio | 0.94 |
| cash ratio | 0.37 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 110.23 |
| operating cycle | 306.50 |
| days of payables outstanding | 57.15 |
| cash conversion cycle | 249.35 |
| receivables turnover | 1.86 |
| payables turnover | 6.39 |
| inventory turnover | 3.31 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.41 |
| debt equity ratio | 11.96 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.92 |
| interest coverage | -716.11 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.00 |
| cash per share | 1.05 |
| operating cash flow per share | 0.00 |
| free cash flow operating cash flow ratio | 0.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time CASI Pharmaceuticals, Inc. (NASDAQ:CASI) reported earnings?
CASI Pharmaceuticals, Inc. (CASI) published its most recent earnings results on 30-09-2024.
What is CASI Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. CASI Pharmaceuticals, Inc. (NASDAQ:CASI)'s trailing twelve months ROE is -390.76%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. CASI Pharmaceuticals, Inc. (CASI) currently has a ROA of -73.14%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did CASI's net profit margin stand at?
CASI reported a profit margin of -137.57% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is CASI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.09 in the most recent quarter. The quick ratio stood at 0.94, with a Debt/Eq ratio of 11.96.